Integra Lifesciences stock had its price target increased by Barclays from $63 to $70 in a research report sent on May 29, according to a Dakota Financial News report.
↧
Integra Lifesciences stock had its price target increased by Barclays from $63 to $70 in a research report sent on May 29, according to a Dakota Financial News report.